IMAT - ultrafast tomography for coronary artery disease Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: art slott who wrote (2809)	1/2/1999 8:01:00 PM
From: Bruce Rozenblit	Read Replies (1) of 3725

These guys don't have the right idea. Imatron has never pushed for widespread testing of the general population but targeted the scanner to asymptomatic people with one or more risk factors between the ages of 45 to 65. Why is it okay to test for prostate cancer, give a routine chest X-ray, check out a colon or give a mammogram to people that carry risk factors for diseases of these areas but a money making rip off to check out someone's heart who carries risk factors for heart disease? Maybe we should tell our auto mechanics to never examine the brakes until after you wrap your car around a telephone pole. Secondly, why down play the value of the machine for diagnostic purposes which can replace many expensive traditional procedures? Sounds like a money saver to me. This tells me that the company has some serious marketing problems if the technology is being evaluated for uses that is was not intended for. This business of 25% bad scans looks awful. Was the machine broke? Is the reliability that bad? The company needs to respond to that test result-big time.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next